Search

everythinglearnresearchcommunity

for

Search:↓

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Low vitamin D might be linked to certain types of hair loss, and supplements could help, but more research is needed.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Most skin changes during pregnancy are harmless and temporary, but some can risk the fetus and need careful treatment.

Higher CRBP1 levels are linked to more severe alopecia areata.

Janus kinase inhibitors show promise in treating autoimmune skin diseases.

People with certain skin diseases have higher levels of the hormone prolactin in their blood.

The document discusses various diseases of the outer ear, categorized by symptoms like redness, crusts, bumps, pus-filled lesions, lumps, ulcers, and hair loss.

Ustekinumab and vedolizumab can help some ulcerative colitis patients with hair regrowth, but results vary.

Higher levels of IL-17A and IL-2 are linked to alopecia areata.

COVID-19 may trigger or worsen rapid hair loss in alopecia areata.

Prolactin levels and gene polymorphism are not linked to vitiligo severity but are related to BMI.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

Dupilumab may help hair regrowth in some patients with severe atopic dermatitis, but results vary.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

Dupilumab may cause significant hair loss, which can reverse after stopping the drug.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

Upadacitinib improved multiple immune-related conditions in one patient.

Baricitinib treatment for alopecia universalis can cause hair regrowth with unexpected whitening.

Innate lymphoid cells help us understand and manage allergic diseases better.

Topical corticosteroids are the preferred first treatment for children with Alopecia Areata.

Samcyprone ointment is effective for treating common warts if a sensitization reaction occurs first.

Estrogen increases a growth factor in hair cells which might affect hair loss.

The meeting discussed vitamin D3's role in fighting tuberculosis, potential treatments for skin conditions like psoriasis, and hair follicle regeneration as a possible solution for hair loss.